PT  - JOURNAL ARTICLE
AU  - Rahimi-Ardabili, Hania
AU  - Feng, Xiaoqi
AU  - Nguyen, Phi-Yen
AU  - Astell-Burt, Thomas
TI  - Have deaths of despair risen during the COVID-19 pandemic? A rapid systematic review
AID  - 10.1101/2022.04.05.22272397
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.05.22272397
4099  - http://medrxiv.org/content/early/2022/04/07/2022.04.05.22272397.short
4100  - http://medrxiv.org/content/early/2022/04/07/2022.04.05.22272397.full
AB  - Objective To systematically review the literature on the impact of the COVID-19 pandemic on deaths of despair (suicide, overdoses and drug-related liver diseases).Methods Five electronic databases were searched using search terms on deaths of despair and COVID-19.Results The review of 70 publications included indicates that there is no change or a decline in the suicide rate during the pandemic compared to the pre-pandemic period. Drug-related deaths such as overdose deaths and liver diseases, however, have been increased compared to the pre-pandemic rate. Findings are mainly from middle-high- and high-income countries and data from low-income countries are lacking. Synthesis of data from subgroup analysis indicates that some groups such as Black people, women and younger age groups would be more vulnerable to socioeconomic disruption during the pandemic.Conclusion Studies included in this review were preliminary and suffered from methodological limitations such as lack of inferential analysis or using provisional data. Further high-quality studies are needed considering the contribution of factors such as disease prevalence, government intervention and environmental characteristics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTAB. was supported by a National Health and Medical Research Council Boosting Dementia Research Leader Fellowship (#1140317). XF was supported by a National Health and Medical Research Council Career Development Fellowship (#1148792).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.